活动主办方也表示："游族网络是引领助残公益实践的标杆性企业之一，其践行的系列公益实践不仅为残障群体提供更多融入社会、实现更大自我价值的机 会，同时也充分彰显了游族网络强烈的社会责任感与使命担当。" 未来，游族网络将继续秉承"科技传颂文明"的使命，承担企业社会责任，积极推动助残理念传播与实践落地，树立"企业主导、多方协同"的公益合作新范 式。 免责声明：此文内容为本网站刊发或转载企业宣传资讯，仅代表作者个人观点，与本网无关。文章不构成投资建议，仅供读者参考，并请自行核实相关内 容。 傅焜在致辞中表示，游族网络长期致力于公益事业，于2015年成立了游族公益基金会，至今已有十个年头，其切实关爱弱势群体、传递爱心力量，并持续开 展公益爱心捐赠活动，公益足迹已遍布西藏、甘南、忠县、内蒙古、新疆等多个地区。 傅焜提到，游族公益基金会不仅定期前往福利机构为残疾人群体送上实质性的帮助和关怀，而且已连续三年向上海市残疾人福利基金会捐赠善款，助力残疾 人就业培训公益项目，致力于拓宽残疾人就业渠道，帮助他们实现自我价值，更好地融入社会。此外，游族网络也曾在去年的FISE极限运动世界巡回赛·上 海站中与熊爪咖啡进行公益合作，将公益带 ...

近日，圣湘生物举办第三季度业绩说明会，在回答投资者关注的基因测序仪项目相关进展时，圣湘生物 董事长、总经理戴立忠表示，在基因测序领域，公司技术平台取得进一步突破，SansureSeq1000（高通 量）、FASTASeq300Dx（桌面级）及FASTASeqS（快速版）三款测序仪形成了较为完整的产品矩阵， 构建了"仪器+试剂+数据"的一体化布局。同时，创新推出的一步法呼吸道病原靶向基因检测、生殖道 病原微生物靶向基因检测、泛感染靶向基因检测等产品已广泛辐射全国多家客户，公司前三季度测序业 务实现同比增长约150%，展现出强劲的增长势头。 戴立忠提到，今年以来，公司拟参与设立常州灵仲创业投资合伙企业、湖南金芙蓉圣湘生物基金等，将 投资于包括AI医疗应用领域及创新药械等医疗行业技术领先、潜在市场空间大的企业。圣维荣泉、维 特力新等基金合伙人均为具有多年投资专业经验、丰富行业资源、成熟管理模式的专业投资机构，借助 其资本市场资源、管理经验和平台优势，结合圣湘生物在行业内多年的专业知识和产业经验，可有效整 合各方优势资源，进一步探索产业与资本赋能良性互动的多元化发展模式，打造共创、共进、共享、共 赢的行业新生态。 此 ...

此外，据田云飞介绍，公司此前引发投资者关注的"何清红等人伪造公司印章"案，截至目前，公安机关 已初步查明"何清红等人伪造公司印章"案的基本事实，何清红已由黄岩区检察院批准逮捕，相关案件仍 在进一步侦查中。 （上证路演） (编辑：杨燕 林辰)关键字： 医疗 近日，济民健康举办第三季度业绩说明会，在回答投资者普遍关注的创新药DB006溶瘤腺病毒注射液相 关进展时，济民健康董事兼总裁田云飞表示，DB006溶瘤腺病毒注射液临床试验受理已满60日，博鳌国 际医院未收到国家药监局药品审评中心对DB006临床试验的否定和质疑意见，博鳌国际医院将按计划推 进相关工作。博鳌国际医院DB006项目目前正稳步推进中，尚未正式启动临床试验工作。 博鳌国际医院DB006溶瘤腺病毒注射液是一款用于治疗晚期恶性实体肿瘤的基因治疗药物，该产品利用 基因工程的方法，对溶瘤病毒进行了多个方面的改造，以实现选择性感染肿瘤细胞、增强病毒的肿瘤特 异性复制能力；同时，该产品通过多个抗肿瘤及免疫调节基因的导入，利用多个靶点杀伤肿瘤。截至目 前，全球市场共有5个溶瘤病毒药物获得审批上市，国内市场进入临床试验阶段的溶瘤病毒药物约7个， 多数处于I/II期。 ...

Core Insights - The company reported a revenue of 17.286 billion with a year-on-year growth of 0.39% for the first nine months of 2025, and a net profit attributable to shareholders of 1.225 billion, reflecting a growth of 10.27% [1] - For the third quarter of 2025, the company achieved a revenue of 5.564 billion, which is a 1.97% increase year-on-year, and a net profit of 0.345 billion, marking a 10.14% growth [1] Group 1 - The company will focus on core strategies such as "professional services, digitalization, supply chain, new retail, operational systems, and talent and culture" to innovate business models centered around customer value [1] - The company aims to enhance its core competitiveness through brand image improvement, professional service capability enhancement, differentiated product category extension, intelligent supply chain construction, and digital technology innovation [1] - The company plans to reconstruct a new service model for health management across the entire lifecycle, contributing to public health and becoming a trusted pharmacy for customers [1] Group 2 - The company adheres to a strategy of "regional focus and steady expansion," utilizing a combination of "new openings, acquisitions, and franchising" to enhance market share and concentration [2] - The company employs a tailored approach for each city in its expansion strategy, ensuring efficient and reasonable store network layout [2]

Core Viewpoint - The company reported a steady improvement in its operational performance for Q3 2025, with revenue and net profit showing slight year-on-year growth, while also addressing the increased health demands due to a flu outbreak by ensuring stable supply of essential medications and protective supplies [1]. Group 1: Financial Performance - For Q3 2025, the company achieved a revenue of 5.296 billion yuan, representing a year-on-year growth of 0.07%, and a net profit attributable to shareholders of 131 million yuan, reflecting a year-on-year increase of 2.6% [1]. - The company has a total of 15,492 stores across 18 provincial markets and over 150 cities, with 9,741 being direct-operated and 5,751 being franchised [1]. Group 2: Supply Chain and Product Strategy - In response to the surge in health demands, the company leveraged its nationwide supply chain and store network to ensure the availability of four key types of medications and protective supplies, with sufficient inventory and stable prices [1]. - Sales of the four key medication categories have seen a month-on-month increase since November [1]. Group 3: Online Business Strategy - The company is focusing on a "category king + seasonal explosive products" strategy to enhance its online business competitiveness, transitioning from quantity to quality [2]. - Key initiatives include refined operations in core business districts using AI and automation, and a marketing platform shift from manual to data-driven management [2]. Group 4: Store Transformation and Customer Experience - The company has initiated a dual-line transformation of its stores, shifting from a transactional to a relational model, aiming to transform staff into trusted health advisors to enhance customer experience [3]. - Measures to improve service quality include restructuring service philosophies, optimizing performance metrics, and enhancing training programs for frontline staff [3]. Group 5: Industry Trends and Challenges - The industry is experiencing accelerated consolidation, with a net decrease of 3,166 stores in Q1 and 4,002 stores in Q2 of 2025, leading to a total of 695,000 stores [4]. - Stricter healthcare policies are pushing for higher compliance and quality in the industry, resulting in the exit of smaller, less compliant players, while larger chains are expected to benefit from this consolidation [4]. - The company aims to capitalize on these industry changes by integrating resources through franchising and alliances to increase market share [4].

经产品管理人充分研究，在目前市场环境下，较难继续按照原投资策略运作本理财产品，产品继续存续 无法实现投资目标。为更好的保护投资者的权益，该理财产品将于2025年12月5日提前终止。 12月3日，北银理财发布公告称，北银理财京华远见春系列诚享5天持有期5号理财产品（产品代码： YJ01250337，产品登记编码：Z7008925000119）于2025年4月18日成立，其中，《产品说明书》"八、 产品的终止与清算"中"（一）产品的提前终止"第6条约定："6.产品管理人根据市场情况认为需要终止 本理财产品。产品管理人提前终止本理财产品的，应提前1个工作日公告本理财产品终止日及本理财产 品终止后的理财本金及收益到账日，并根据本理财产品销售文件信息披露约定的渠道进行公告。" ...

（国家金融监督管理总局） 12月3日，国家金融监督管理总局陕西监管局发布批复，同意长安银行增资扩股方案，募集股份不超过26.11亿股，募集资金全部用于补充核心一级资本。 批复要求，长安银行应严格审查股东资质，按程序向陕西金融监管局申请核准相关股东资格，并严格核查入股资金来源，确保入股资金为来源合法的自有资 金，不得以委托资金、债务资金等非自有资金入股，确保增资扩股的真实性。同时，该行应在募集资金到位后及时向陕西金融监管局提出变更注册资本申 请，严格遵照有关法律法规完成变更事宜。 ...

12月4日，据住房城乡建设部消息，2025年全国计划新开工改造城镇老旧小区2.5万个。根据各地统计上 报数据，1-10月份，全国新开工改造城镇老旧小区2.51万个。分地区看，河北、内蒙古、辽宁、吉林、 上海、江苏、安徽、福建、江西、海南、重庆、云南、陕西、甘肃、青海、新疆生产建设兵团等16个地 区已完成年度城镇老旧小区改造计划。 今年1-10月全国新开工改造城镇老旧小区2.51万个 ...

Core Viewpoint - The approval of Innovation Industry for listing on the Hong Kong Stock Exchange marks a significant development in China's aluminum industry, highlighting the company's role as a benchmark enterprise in the sector [1] Group 1: Company Actions - China Merchants Bank Wealth Management successfully allocated over 10 million yuan in the IPO of Innovation Industry, with 11 of its products included in the allocation [1] - The participation in Innovation Industry's IPO is part of the company's efforts to promote green finance and support the internationalization of Chinese manufacturing enterprises [1] Group 2: Industry Implications - The listing of Innovation Industry is seen as a typical case of the company's commitment to serving the real economy, fostering innovation, and supporting green development [1]

12月4日，光莆股份（300632）在互动平台向投资者表示，公司业务发展战略聚焦在传感器领域，重点 聚焦半导体光集成传感封测、智能传感器模组和传感器创新应用场景，并积极推动光集成传感技术、智 能物联硬件技术在养老领域的创新应用。2025年1至9月份，光莆股份实现营收6.19亿元，同比下降 3.32%；实现归母净利润0.44亿元，同比下降38.35%。 公司业务发展战略聚焦在传感器领域，重点聚焦半导体光集成传感封测、智能传感器模组和传感器创新 应用场景，并积极推动光集成传感技术、智能物联硬件技术在养老领域的创新应用。 ...